The pharmaceutical industry has never been more ambitious. Life sciences leaders are racing to personalize medicine, bring therapies to market faster, and scale the promise of AI. But one factor continues to undermine progress across every stage of the value chain: data that isn’t trusted, governed, or accessible when and where it matters most.

We see it every day.

• Clinical operations slowed by fragmented site and patient data
• Regulatory filings delayed by inconsistent submissions
• Pharmacovigilance systems strained by reactive, manual workflows
• Commercial models struggling to unify physician and payer data
• AI pilots failing due to poor data quality and lack of readiness

The reality is this: Pharma doesn’t just need more data – it needs data that it can trust.

Across the enterprise, we hear the same challenges echoed:

1. Fragmented Data lives in silos, across global sites, CROs, labs, and legacy systems
2. Poor Quality: Incomplete, duplicative, and conflicting records derail downstream use
3. Lack of Governance: Data access is either too limited, or too uncontrolled
4. Inflexible Infrastructure: Legacy tools can’t scale to meet cloud or AI demands

These issues aren’t just technical, they’re strategic. They limit trial agility, delay product approvals, and erode the confidence required to act quickly in fast-moving markets.

Data-mature organizations in pharma are investing not just in applications or analytics – but in data intelligence. That means creating a governed, cloud-native foundation for trusted, reusable, and AI-ready data.

At Informatica, we partner with top life sciences companies to operationalize this vision through the Intelligent Data Management Cloud (IDMC), a platform engineered for:

• Master Data Management: Unified patient, provider, trial, and product records
• Automated Data Quality: AI-powered cleansing, enrichment, and deduplication
• Enterprise Data Governance: Policy enforcement, lineage, and stewardship at scale
• Self-Service Access: Data marketplaces to empower business and clinical teams
• Privacy and Protection: Role-based access and compliance with global regulations
• Cloud Scalability: Multi-cloud flexibility to adapt globally, deploy locally

With IDMC, pharma organizations gain a single source of truth and the agility to activate data wherever the need arises – from trial design to real-world evidence to commercialization.

Here’s how trusted data is transforming key pharma use cases:

These aren’t future state ambitions. They’re current state advantages – achieved by pharma leaders who see data not as a back-office function but an enterprise-wide enabler.

In an industry defined by complexity, compliance, and competition, trusted data is becoming pharma’s most strategic asset. It shortens timelines, increases confidence in AI, enhances regulatory readiness, and ultimately – it saves lives.

The pharmaceutical industry already knows how to innovate. Now it needs a data foundation that matches that ambition.

At Informatica, we’re proud to support life sciences organizations as they modernize the discovery, development, and delivery of therapies to the world.

Let’s build the data backbone of your next breakthrough.

For more information, please read this brief.